Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACCW) is a blank-check company sponsored by affiliates of Oaktree Capital Management, L.P., the Los Angeles-based alternative investment manager. The company filed an S-1/A amendment with the SEC on October 18, 2024, advancing its registration statement for a life sciences-focused initial public offering. As the third SPAC vehicle in Oaktree's acquisition corp series, the company is targeting a business combination within the healthcare and life sciences sector. The 2024 filing reflects continued institutional interest in SPAC formation within the life sciences space. To access complete filing history, deal timelines, and sponsor analytics for Oaktree Acquisition Corp. III and hundreds of other SPACs, sign up for full data at SpacDesk.